Investigation of carbachol and PACAP38 in a human model of migraine

Keyphrases

• Human Models of Migraine 100%
• Carbachol 100%
• Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) 100%
• Vasoactive Intestinal Peptide 63%
• Inflammation Cells 36%
• Neurogenic Inflammation 36%
• Migraine 27%
• Migraine Patients 27%
• Acetylcholine 27%
• Migraine-like 27%
• Headache 18%
• Central Sensitization 18%
• Best Model 9%
• Volunteer Patients 9%
• Migraine Pain 9%
• Acute Pain 9%
• Receptor Antagonism 9%
• Signaling Molecules 9%
• Vasodilatation 9%
• Maximum Tolerated Dose 9%
• Head Pain 9%
• Migraine Treatment 9%
• Migraine Attack 9%
• Sensory Nerve Fibers 9%
• New Targets 9%
• Nitric Oxide 9%
• Dilatation 9%
• Placebo-controlled 9%
• VPAC2 Receptor 9%
• Healthy Volunteers 9%
• Migraine Pathophysiology 9%
• Experimental Migraine 9%

Medicine and Dentistry

• Migraine 100%
• Carbachol 100%
• Pituitary Adenylate Cyclase-Activating Polypeptide 100%
• Vasoactive Intestinal Polypeptide 46%
• Neurogenic Inflammation 26%
• Headache 20%
• Receptor 20%
• Acetylcholine 20%
• Sensitization 13%
• Infusion 13%
• Pathophysiology 6%
• Migraine Treatment 6%
• Afferent Nerve Fiber 6%
• Hypophysis Adenylate Cyclase Activating Polypeptide 6%
• Vasodilatation 6%
• Placebo 6%
• Pain 6%
• Nitric Oxide 6%
• Skin Pain 6%
• Nerve Fiber 6%
• Volunteer 6%
• Signaling Molecule 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Carbachol 100%
• Migraine 100%
• Adenylate Cyclase 100%
• Vasoactive Intestinal Polypeptide 43%
• Neurogenic Inflammation 25%
• Receptor 18%
• Headache 18%
• Acetylcholine 18%
• Normal Human 12%
• Nitric Oxide 6%
• Pathophysiology 6%
• Placebo 6%
• Hypophysis Adenylate Cyclase Activating Polypeptide 6%
• Pain 6%